D.E. Shaw & Co

D.E. Shaw & Co’s Regulus Therapeutics RGLS Stock Holding History

D.E. Shaw & Co’s Portfolio RGLS Stock Details RGLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-228	Closed	-$28K	–	3742
2017 Q4	$28K	Sell	228 -20	-8%	-$2.53K	﹤0.01%	3541
2017 Q3	$37K	Buy	+248	New	+$31.2K	﹤0.01%	3413
2017 Q1	–	Sell	-516	Closed	-$139K	–	3547
2016 Q4	$139K	Buy	516 +42	+9%	+$13.7K	﹤0.01%	3322
2016 Q3	$187K	Buy	+474	New	+$195K	﹤0.01%	3214
2016 Q2	–	Sell	-572	Closed	-$476K	–	3496
2016 Q1	$476K	Sell	572 -322	-36%	-$256K	﹤0.01%	2810
2015 Q4	$935K	Buy	894 +462	+107%	+$463K	﹤0.01%	2682
2015 Q3	$339K	Buy	+432	New	+$443K	﹤0.01%	3289
2015 Q2	–	Sell	-104	Closed	-$212K	–	3848
2015 Q1	$212K	Buy	+104	New	+$226K	﹤0.01%	3433
2013 Q4	–	Sell	-212	Closed	-$240K	–	4659
2013 Q3	$240K	Buy	+212	New	+$250K	﹤0.01%	4010

Other funds holding RGLS

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

South Dakota Investment Council Sioux Falls, South Dakota $5.24B AUM 22.1% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Ascend Capital Orinda, California $1.99B AUM 10.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return